Font Size: a A A
Keyword [Iodine-131]
Result: 1 - 20 | Page: 1 of 3
1. Experimental Study On Biodistribution And Anticancer Activity Of ～(131)I-Herceptin In Breast Cancer Xenograft
2. An Experimental Study On Radioimmunotherapy For Xenografts Of Human Esophageal Carcinoma In Nude Mice
3. The Studies Of Thyroid Carcinoma Cells Re-differentiation Induced With Retinoic Acid And Trichostatin A
4. Experimental Study On Irradiation Combined With Targeted Therapy
5. Treatment Hepatocellular Carcinoma With 131I-Labeled-Metuximab (Licartin) Combination With Transcatheter Arterial Chemoembolization (TACE): A Clinical Study
6. Clinical Study Of Adolescent Hyperthyroidism After Iodine-131 Therapy
7. Techniques Of Anti-CD20 Monoclonal Antibody Labeling With ～(131)I And Experimental Study On Treatment For Nude Mice Xenografted With Tumor
8. The Application Of Premature Chromosome Condensation Induce By Calyculin A In Radiobiodosimeter
9. The Study Value Of ～(99m)Tc-MIBI Imaging For The Follow-up Patients With Differentiated Thyroid Carcinoma After Iodine-131 Ablation Residual Thyroid Tissue
10. Clinical Study Of Iodine-131 Therapy Of Graves' Disease
11. Establishment Of Methodology And Treating Efficiency To Treat Hyperthyroidism With Low Dose Iodine-131 Combined With PTU
12. Clinical Study On The Therapeutic Effect Of Combined Iodine-131 And "Fufang Jiakang Tablets" On Graves' Disease
13. The Public Radiation Protection From Patients Received Iodine-131 Treatment For Hyperthyroidism And Differentiated Thyroid Carcinoma
14. The Experimental Study Of Iodine-131 Brachytherapy For Brain Gliomas
15. Clinical Retrospective Analysis Of Iodine-131 Therapy For Graves' Disease
16. Curative Effect Analysis And Effects Of Thyroid Size In Radioactive Iodine-131 Therapy For Graves Disease
17. Changes In Serum Reactive Oxygen Species After Iodine-131 Treatment And Its Clinical Significance In Graves Disease
18. Clinical Study Of Removing Residual Tissue After The Ablation Of Thyroid Cancer By 131Ⅰ Plus Lithium Carbonate
19. The Correlation Between The Drift Rate Of Serum IL-2/IL-6 And Thyroid Iodine-131 Turnover Rate In Patients With Graves Disease
20. Serum Differential Proteomic Analysis And Screening Model Establishment Using SELDI-TOF-MS In Patients With Papillary Thyroid Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to